In the present meta-analysis, we identified eight SNPs associated with Lp-PLA2 mass or activity which might contribute to the regulation of plasma levels and give insight as to whether Lp-PLA2 is a risk factor or risk marker for CHD. Most of these genetic loci were in regions that have already been associated with levels of lipoproteins.